<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Crit Care</journal-id><journal-title>Critical Care</journal-title><issn pub-type="ppub">1364-8535</issn><issn pub-type="epub">1466-609X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">cc7685</article-id><article-id pub-id-type="pmid">19226440</article-id><article-id pub-id-type="doi">10.1186/cc7685</article-id><article-categories><subj-group subj-group-type="heading"><subject>Commentary</subject></subj-group></article-categories><title-group><article-title>Excess circulating angiopoietin-2 levels in sepsis: harbinger of death in the intensive care unit?</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Giuliano</surname><given-names>John S</given-names><suffix>Jr</suffix></name><xref ref-type="aff" rid="I1">1</xref><email>john.giuliano@yale.edu</email></contrib><contrib id="A2" corresp="yes" contrib-type="author"><name><surname>Wheeler</surname><given-names>Derek S</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>derek.wheeler@cchmc.org</email></contrib></contrib-group><aff id="I1"><label>1</label>Division of Critical Care Medicine, Department of Pediatrics, Yale University School of Medicine, 333 Ceder St, Yale-New Haven Children's Hospital, West Pavilion 2nd floor, New Haven, CT 06510, USA</aff><aff id="I2"><label>2</label>Division of Critical Care Medicine, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, 3333 Burnet Avenue, Cincinnati, OH 45229-3039, USA</aff><pub-date pub-type="ppub"><year>2009</year></pub-date><pub-date pub-type="epub"><day>27</day><month>1</month><year>2009</year></pub-date><volume>13</volume><issue>1</issue><fpage>114</fpage><lpage>114</lpage><ext-link ext-link-type="uri" xlink:href="http://ccforum.com/content/13/1/114"/><permissions><copyright-statement>Copyright &#x000a9; 2009 BioMed Central Ltd</copyright-statement><copyright-year>2009</copyright-year><copyright-holder>BioMed Central Ltd</copyright-holder></permissions><abstract><p>The early recognition and management of sepsis remain the greatest challenges in the field of critical care medicine. Endothelial injury is one of the hallmarks of sepsis, leading to capillary leak, microcirculatory dysfunction, organ failure, and eventual death in many critically ill patients. The angiogenic growth factors, angiopoietin (angpt)-1 and angpt-2, act upon the Tie-2 receptor in opposing roles. Angpt-2 has been found in abundance in septic patients when compared with healthy controls. In the study by K&#x000fc;mpers and colleagues in the previous issue of <italic>Critical Care</italic>, angpt-2 levels correlated with markers of tissue hypoxia, disease severity, and mortality in septic adults. However, the temporal kinetics of the angiopoietins were not assessed. It remains to be seen whether angpt-2 levels will function solely as an early marker of sepsis or whether the manipulation of the angpt/Tie-2 system will become a rational therapeutic target for the management of sepsis.</p></abstract></article-meta><notes><p>See related research by K&#x000fc;mpers <italic>et al.</italic>, <ext-link ext-link-type="uri" xlink:href="http://ccforum.com/content/12/6/R147"/></p></notes></front><body><sec><title/><p>In the previous issue of <italic>Critical Care</italic>, K&#x000fc;mpers and colleagues [<xref ref-type="bibr" rid="B1">1</xref>] demonstrated a direct correlation between increased peripheral blood levels of the vascular growth factor, angiopoietin (angpt)-2, and mortality in 43 critically ill adults with sepsis. Endothelial injury is one of the main hallmarks of sepsis, leading to capillary leak, microcirculatory dysfunction, organ failure, and eventual death in many critically ill patients [<xref ref-type="bibr" rid="B2">2</xref>]. Angpt-1 and angpt-2 are two of the best-characterized members of a family of endothelial-derived vascular growth factors necessary for both normal and pathologic angiogenesis and vasculogenesis. Both angpt-1 and angpt-2 appear to bind to the tyrosine kinase receptor, Tie-2, found primarily on the luminal surface of endothelial cells [<xref ref-type="bibr" rid="B3">3</xref>]. Recent studies have also shown that the Tie-2 receptor may be found on certain populations of peripheral blood monocytes [<xref ref-type="bibr" rid="B4">4</xref>], although the function and role of the Tie-2 receptor in the host innate immune response remain relatively unexplored. Angpt-1 and angpt-2 appear to have directly opposing roles during health and disease states. Angpt-1 is a Tie-2 agonist and promotes endothelial stabilization and quiescence, whereas angpt-2 is a Tie-2 antagonist and promotes endothelial activation, destabilization, and inflammation [<xref ref-type="bibr" rid="B3">3</xref>]. As such, the relative balance between angpt-2 and angpt-1 at the Tie-2 receptor may be more relevant to the pathobiology of sepsis than the absolute levels of the individual growth factors [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>].</p><p>Several studies have demonstrated increased peripheral blood levels of angpt-2 in critically ill patients with sepsis [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B9">9</xref>], multiple trauma [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref>], acute lung injury (ALI) [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>], and cardiopulmonary bypass [<xref ref-type="bibr" rid="B6">6</xref>] when compared with healthy controls. More importantly, increased angpt-2 levels appear to be associated with adverse outcomes [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B12">12</xref>]. For example, the study of K&#x000fc;mpers and colleagues [<xref ref-type="bibr" rid="B1">1</xref>] showed that increased peripheral blood angpt-2 levels correlated with surrogate markers of tissue hypoxia, disease severity, and mortality in 43 critically ill adults with sepsis. Also of note, consistent with the opposing roles of angpt-2 and angpt-1 on the Tie-2 receptor, peripheral blood levels of angpt-1 were significantly lower in the patients with sepsis compared with healthy controls. Unfortunately, in the study of K&#x000fc;mpers and colleagues, similar to the aforementioned studies, the temporal kinetics of angpt-1 and angpt-2 were not assessed as blood samples were collected upon the first day of admission to the intensive care unit only. Angpt-2 is stored in the Weibel-Palade bodies within endothelial cells [<xref ref-type="bibr" rid="B14">14</xref>] in a more or less prepackaged form. It is therefore not surprising that angpt-2 levels are increased early in response to endothelial activation or injury. Whether angpt-2 levels remain increased in critically ill patients with sepsis has not been directly addressed and is a question for future investigation. It is certainly tempting to speculate that peripheral blood angpt-2 levels would be an ideal biomarker of early endothelial activation and injury. Similarly, whether angpt-1 levels remain decreased in critically ill patients who eventually succumb to their illness is an interesting question. Angpt-1 may be a biomarker of endothelial recovery; however, given its purported anti-inflammatory role, angpt-1 would appear to be an attractive therapeutic target as well. To this end, several studies have suggested that manipulating the ratio of angpt-2 to angpt-1 by augmenting angpt-1 levels may represent an ideal therapeutic strategy for patients with sepsis and ALI [<xref ref-type="bibr" rid="B15">15</xref>].</p><p>Important translational laboratory studies are necessary to show that increased angpt-2 levels in critically ill patients are more than just an epiphenomenon. The role of angpt-2 in the pathobiology of sepsis and ALI needs to be further elucidated by using <italic>in vitro </italic>cell-based studies and animal models of critical illness. Similarly, the presence of the Tie-2 receptor on certain subpopulations of peripheral blood monocytes [<xref ref-type="bibr" rid="B4">4</xref>] suggests a larger role for angpt-2 in the host innate immune response. Finally, manipulation of the angpt/Tie-2 system may be a rational therapeutic strategy for the management of critically ill patients with sepsis and ALI. All of these questions remain an active focus in several laboratories, including our own.</p></sec><sec><title>Abbreviations</title><p>ALI: acute lung injury; angpt: angiopoietin.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>The authors' research is funded by the National Institutes of Health (Bethesda, MD, USA) (grant numbers 5KO8GM077432 and 1R03HD058246).</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>K&#x000fc;mpers</surname><given-names>P</given-names></name><name><surname>Lukasz</surname><given-names>A</given-names></name><name><surname>David</surname><given-names>S</given-names></name><name><surname>Horn</surname><given-names>R</given-names></name><name><surname>Hafer</surname><given-names>C</given-names></name><name><surname>Faulhaber-Walter</surname><given-names>R</given-names></name><name><surname>Fliser</surname><given-names>D</given-names></name><name><surname>Haller</surname><given-names>H</given-names></name><name><surname>Kielstein</surname><given-names>JT</given-names></name></person-group><article-title>Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients</article-title><source>Crit Care</source><year>2008</year><volume>12</volume><fpage>R147</fpage><pub-id pub-id-type="pmid">19025590</pub-id><pub-id pub-id-type="doi">10.1186/cc7130</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spronk</surname><given-names>PE</given-names></name><name><surname>Zandstra</surname><given-names>DF</given-names></name><name><surname>Ince</surname><given-names>C</given-names></name></person-group><article-title>Bench-to-bedside review: sepsis is a disease of the microcirculation</article-title><source>Crit Care</source><year>2004</year><volume>8</volume><fpage>462</fpage><lpage>468</lpage><pub-id pub-id-type="pmid">15566617</pub-id><pub-id pub-id-type="doi">10.1186/cc2894</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fiedler</surname><given-names>U</given-names></name><name><surname>Augustin</surname><given-names>HG</given-names></name></person-group><article-title>Angiopoietins: a link between angiogenesis and inflammation</article-title><source>Trends Immunol</source><year>2006</year><volume>27</volume><fpage>552</fpage><lpage>558</lpage><pub-id pub-id-type="pmid">17045842</pub-id><pub-id pub-id-type="doi">10.1016/j.it.2006.10.004</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murdoch</surname><given-names>C</given-names></name><name><surname>Tazzyman</surname><given-names>S</given-names></name><name><surname>Webster</surname><given-names>S</given-names></name><name><surname>Lewis</surname><given-names>CE</given-names></name></person-group><article-title>Expression of Tie-2 by human monocytes and their response to angiopoietin-2</article-title><source>J Immunol</source><year>2007</year><volume>178</volume><fpage>7405</fpage><lpage>7411</lpage><pub-id pub-id-type="pmid">17513791</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giuliano</surname><given-names>JS</given-names><suffix>Jr</suffix></name><name><surname>Lahni</surname><given-names>PM</given-names></name><name><surname>Harmon</surname><given-names>K</given-names></name><name><surname>Wong</surname><given-names>HR</given-names></name><name><surname>Doughty</surname><given-names>LA</given-names></name><name><surname>Carcillo</surname><given-names>JA</given-names></name><name><surname>Zingarelli</surname><given-names>B</given-names></name><name><surname>Sukhatme</surname><given-names>VP</given-names></name><name><surname>Parikh</surname><given-names>SM</given-names></name><name><surname>Wheeler</surname><given-names>DS</given-names></name></person-group><article-title>Admission angiopoietin levels in children with septic shock</article-title><source>Shock</source><year>2007</year><volume>28</volume><fpage>650</fpage><lpage>654</lpage><pub-id pub-id-type="pmid">18092380</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giuliano</surname><given-names>JS</given-names><suffix>Jr</suffix></name><name><surname>Lahni</surname><given-names>PM</given-names></name><name><surname>Bigham</surname><given-names>MT</given-names></name><name><surname>Manning</surname><given-names>PB</given-names></name><name><surname>Nelson</surname><given-names>DP</given-names></name><name><surname>Wong</surname><given-names>HR</given-names></name><name><surname>Wheeler</surname><given-names>DS</given-names></name></person-group><article-title>Plasma angiopoietin-2 levels increase in children following cardiopulmonary bypass</article-title><source>Intensive Care Med</source><year>2008</year><volume>34</volume><fpage>1851</fpage><lpage>1857</lpage><pub-id pub-id-type="pmid">18516587</pub-id><pub-id pub-id-type="doi">10.1007/s00134-008-1174-9</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parikh</surname><given-names>SM</given-names></name><name><surname>Mammoto</surname><given-names>T</given-names></name><name><surname>Schultz</surname><given-names>A</given-names></name><name><surname>Yuan</surname><given-names>HT</given-names></name><name><surname>Christiani</surname><given-names>D</given-names></name><name><surname>Karumanchi</surname><given-names>SA</given-names></name><name><surname>Sukhatme</surname><given-names>VP</given-names></name></person-group><article-title>Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans</article-title><source>PLoS Med</source><year>2006</year><volume>3</volume><fpage>e46</fpage><pub-id pub-id-type="pmid">16417407</pub-id><pub-id pub-id-type="doi">10.1371/journal.pmed.0030046</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Orfanos</surname><given-names>SE</given-names></name><name><surname>Kotanidou</surname><given-names>A</given-names></name><name><surname>Glynos</surname><given-names>C</given-names></name><name><surname>Athanasiou</surname><given-names>C</given-names></name><name><surname>Tsigkos</surname><given-names>S</given-names></name><name><surname>Dimopoulou</surname><given-names>I</given-names></name><name><surname>Sotiropoulou</surname><given-names>C</given-names></name><name><surname>Zakynthinos</surname><given-names>S</given-names></name><name><surname>Armaganidis</surname><given-names>A</given-names></name><name><surname>Papapetropoulos</surname><given-names>A</given-names></name><name><surname>Roussos</surname><given-names>C</given-names></name></person-group><article-title>Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators</article-title><source>Crit Care Med</source><year>2007</year><volume>35</volume><fpage>199</fpage><lpage>206</lpage><pub-id pub-id-type="pmid">17110873</pub-id><pub-id pub-id-type="doi">10.1097/01.CCM.0000251640.77679.D7</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Siner</surname><given-names>JM</given-names></name><name><surname>Bhandari</surname><given-names>V</given-names></name><name><surname>Engle</surname><given-names>KM</given-names></name><name><surname>Elias</surname><given-names>JA</given-names></name><name><surname>Siegel</surname><given-names>MD</given-names></name></person-group><article-title>Elevated serum angiopoietin 2 levels are associated with increased mortality in sepsis</article-title><source>Shock</source><year>2008</year><comment></comment><pub-id pub-id-type="pmid">18791490</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ganter</surname><given-names>MT</given-names></name><name><surname>Cohen</surname><given-names>MJ</given-names></name><name><surname>Brohi</surname><given-names>K</given-names></name><name><surname>Chesebro</surname><given-names>BB</given-names></name><name><surname>Staudenmayer</surname><given-names>KL</given-names></name><name><surname>Rahn</surname><given-names>P</given-names></name><name><surname>Christiaans</surname><given-names>SC</given-names></name><name><surname>Bir</surname><given-names>ND</given-names></name><name><surname>Pittet</surname><given-names>JF</given-names></name></person-group><article-title>Angiopoietin-2, marker and mediator of endothelial activation with prognostic significance early after trauma?</article-title><source>Ann Surg</source><year>2008</year><volume>247</volume><fpage>320</fpage><lpage>326</lpage><pub-id pub-id-type="pmid">18216540</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giamarellos-Bourboulis</surname><given-names>EJ</given-names></name><name><surname>Kanellakopoulou</surname><given-names>K</given-names></name><name><surname>Pelekanou</surname><given-names>A</given-names></name><name><surname>Tsaganos</surname><given-names>T</given-names></name><name><surname>Kotzampassi</surname><given-names>K</given-names></name></person-group><article-title>Kinetics of angiopoietin-2 in serum of multi-trauma patients: correlation with patient severity</article-title><source>Cytokine</source><year>2008</year><volume>44</volume><fpage>310</fpage><lpage>313</lpage><pub-id pub-id-type="pmid">18952457</pub-id><pub-id pub-id-type="doi">10.1016/j.cyto.2008.09.003</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gallagher</surname><given-names>DC</given-names></name><name><surname>Parikh</surname><given-names>SM</given-names></name><name><surname>Balonov</surname><given-names>K</given-names></name><name><surname>Miller</surname><given-names>A</given-names></name><name><surname>Gautam</surname><given-names>S</given-names></name><name><surname>Talmor</surname><given-names>D</given-names></name><name><surname>Sukhatme</surname><given-names>VP</given-names></name></person-group><article-title>Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndrome</article-title><source>Shock</source><year>2008</year><volume>29</volume><fpage>656</fpage><lpage>661</lpage><pub-id pub-id-type="pmid">18091573</pub-id><pub-id pub-id-type="doi">10.1097/SHK.0b013e31815dd92f</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heijden</surname><given-names>M van der</given-names></name><name><surname>van Nieuw Amerongen</surname><given-names>GP</given-names></name><name><surname>Koolwijk</surname><given-names>P</given-names></name><name><surname>van Hinsbergh</surname><given-names>VW</given-names></name><name><surname>Groeneveld</surname><given-names>AB</given-names></name></person-group><article-title>Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients</article-title><source>Thorax</source><year>2008</year><volume>63</volume><fpage>903</fpage><lpage>909</lpage><pub-id pub-id-type="pmid">18559364</pub-id><pub-id pub-id-type="doi">10.1136/thx.2007.087387</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fiedler</surname><given-names>U</given-names></name><name><surname>Scharpfenecker</surname><given-names>M</given-names></name><name><surname>Koidl</surname><given-names>S</given-names></name><name><surname>Hegen</surname><given-names>A</given-names></name><name><surname>Grunow</surname><given-names>V</given-names></name><name><surname>Schmidt</surname><given-names>JM</given-names></name><name><surname>Kriz</surname><given-names>W</given-names></name><name><surname>Thurston</surname><given-names>G</given-names></name><name><surname>Augustin</surname><given-names>HG</given-names></name></person-group><article-title>The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies</article-title><source>Blood</source><year>2004</year><volume>103</volume><fpage>4150</fpage><lpage>4156</lpage><pub-id pub-id-type="pmid">14976056</pub-id><pub-id pub-id-type="doi">10.1182/blood-2003-10-3685</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van der Heijden</surname><given-names>M</given-names></name><name><surname>van Nieuw Amerongen</surname><given-names>GP</given-names></name><name><surname>Chedamni</surname><given-names>S</given-names></name><name><surname>van Hinsbergh</surname><given-names>VW</given-names></name><name><surname>Johan Groeneveld</surname><given-names>AB</given-names></name></person-group><article-title>The angiopoietin-Tie2 system as a therapeutic target in sepsis and acute lung injury</article-title><source>Expert Opin Ther Targets</source><year>2008</year><volume>13</volume><fpage>39</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">19063705</pub-id><pub-id pub-id-type="doi">10.1517/14728220802626256</pub-id></citation></ref></ref-list></back></article> 